MDT Maintained by UBS -- Price Target Raised to $110

gurufocus.com · 2026-09-03

On September 3, 2026, UBS analyst Priya Sachdeva maintained a 'Buy' rating for Medtronic (MDT) while raising the price target from $100.00 to $110.00, marking a

TickrTrends take: UBS maintained its stance on Medtronic while lifting its price target to $110, signaling confidence in the company's trajectory within the Healthcare sector. Given TickrTrends' current assessment of MDT as fairly valued, this analyst action suggests the market price may have room to align with UBS's target, making the gap between current valuation and the target a metric worth monitoring for investors focused on fundamental value. The maintenance of coverage combined with an increased price target could indicate analyst expectations for earnings growth or operational improvements that would need to materialize for the valuation to shift from its current fairly valued position.

Read the full story at gurufocus.com →